Internal Medicine · Lecanto, FL
NPI
1790942555
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
2
Hospital affiliations
2063 N Lecanto Hwy Ste 1
Lecanto, FL, 34461
Phone (352) 470-0230
Groups this clinician bills Medicare through
Medicare paid, 2024
$187K
2,087 services
Medicare patients, 2024
643
Average age 78
Drug cost, 2024
$1.0M
3,102 prescriptions
Company payments, 2025
$0
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Smita Padala was code 99214 (office e&m - established), 827 times for 379 patients. In total Smita Padala billed 2,087 services in 8 codes, and Medicare paid $187K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 827 | 379 | $89.20 | $74K |
| 99233 Hospital E&M - Subsequent | Facility | 516 | 212 | $87.42 | $45K |
| 99232 Hospital E&M - Subsequent | Facility | 351 | 146 | $58.05 | $20K |
| 99223 Hospital E&M - Initial | Facility | 273 | 235 | $127.50 | $35K |
| 99204 Office E&M - New | Office | 107 | 107 | $114.78 | $12K |
By year: 2022 $203K for 2,252 services; 2023 $216K for 2,360 services; 2024 $187K for 2,087 services.
Medicare prescription drug claims, 2024
In 2024, the drug Smita Padala prescribed most often to Medicare patients was Calcitriol, with 377 prescriptions and refills. In total Smita Padala wrote 3,102 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Calcitriol Generic | 377 | 1,036 | 128 | $6,551 |
| Allopurinol Generic | 324 | 760 | 105 | $2,217 |
| Losartan Potassium Generic | 216 | 519 | 70 | $1,930 |
| Amlodipine Besylate Generic | 184 | 379 | 54 | $976 |
| Hydralazine Hcl Generic | 151 | 339 | 62 | $2,294 |
| Lisinopril Generic | 111 | 295 | 38 | $762 |
| Farxiga Dapagliflozin Propanediol | 100 | 168 | 31 | $93K |
| Metoprolol Succinate Generic | 91 | 195 | 28 | $1,050 |
| Telmisartan Generic | 84 | 192 | 25 | $2,444 |
| Midodrine Hcl Generic | 78 | 140 | 40 | $3,661 |
| Metolazone Generic | 68 | 119 | 31 | $756 |
| Carvedilol Generic | 63 | 118 | 20 | $406 |
| Spironolactone Generic | 63 | 145 | 28 | $682 |
| Bumetanide Generic | 61 | 130 | 24 | $2,390 |
| Jardiance Empagliflozin | 59 | 83 | 17 | $44K |
Brand drugs: 291 claims; generic drugs: 2,811 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Smita Padala $0 (- in general payments such as food, travel and fees) from 2 companies.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.